Aquestive Therapeutics, Inc. business relationships

Companies named in Aquestive Therapeutics, Inc.’s 10-K filed 2026-03-04, and public companies whose annual reports name Aquestive Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.4 / 10
AI naming: 59 / 100
Agent readiness: 30 / 100
AI adoption: 0 / 100

Named in Aquestive Therapeutics, Inc.’s annual report 1

Cynapsus Therapeutics Inc.Licensor4.2
“| | | | License Agreement, by and between MonoSol Rx, LLC (now Aquestive Therapeutics, Inc.) and Cynapsus Therapeutics Inc., dated as of April 1, 2016 (filed as Exhibit 10.12 to the Registration Statement on Form S-1 of the Company (File No. 333-225924), as filed on June 27, 2018, and incorporated b...” SEC filing

Companies whose annual reports name Aquestive Therapeutics, Inc. 2

Indivior Pharmaceuticals, Inc. (INDV)names it as supplier6.1
“SUBOXONE Film is manufactured under an exclusive license and supply agreement with Aquestive Therapeutics.” SEC filing
ZEVRA THERAPEUTICS, INC. (ZVRA)names it as licensor4.7
“In connection with the AZSTARYS License Agreement, the Company pays Aquestive Therapeutics, Inc. ("Aquestive") a royalty equal to 10 % of all regulatory milestone and royalty payments.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.